111 related articles for article (PubMed ID: 19153927)
1. Risperidone and pituitary adenomas.
Sainani A; Cabral S
Aust N Z J Psychiatry; 2009 Feb; 43(2):177. PubMed ID: 19153927
[No Abstract] [Full Text] [Related]
2. Atypical antipsychotics and pituitary neoplasms in the WHO database.
Doraiswamy PM; Schott G; Star K; Edwards R; Mueller-Oerlinghausen B
Psychopharmacol Bull; 2007; 40(1):74-6. PubMed ID: 17285098
[TBL] [Abstract][Full Text] [Related]
3. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V
J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
[No Abstract] [Full Text] [Related]
4. Risperidone and dysphagia.
Varghese ST; Balhara YP; George SA; Sagar R
J Postgrad Med; 2006; 52(4):327-8. PubMed ID: 17102565
[No Abstract] [Full Text] [Related]
5. Effect of risperidone on ghrelin and glucose in schizophrenia.
Cohen D
Psychiatry Clin Neurosci; 2007 Oct; 61(5):576. PubMed ID: 17875041
[No Abstract] [Full Text] [Related]
6. Risperidone-induced delirium.
Tavcar R; Dernovsek MZ
Can J Psychiatry; 1998 Mar; 43(2):194. PubMed ID: 9533974
[No Abstract] [Full Text] [Related]
7. Risperidone-associated increase in triglyceride levels.
Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
[No Abstract] [Full Text] [Related]
8. Self-limited erythema multiforme with risperidone.
Burke GV; Wong DA; Saunders CS; Pierre JM
Gen Hosp Psychiatry; 2009; 31(3):295-6. PubMed ID: 19410111
[No Abstract] [Full Text] [Related]
9. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
[TBL] [Abstract][Full Text] [Related]
10. Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia.
Pandina GJ; Canuso CM; Youssef E; Kujawa M; Mahmoud R
Hum Psychopharmacol; 2007 Jul; 22(5):326-7; author reply 328. PubMed ID: 17599334
[No Abstract] [Full Text] [Related]
11. New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone.
Sato Y; Yasui-Furukori N; Kaneko S; Moriyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):577-8. PubMed ID: 17919798
[No Abstract] [Full Text] [Related]
12. Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient.
Lu CH; Yan YH
Diabetes Res Clin Pract; 2009 Feb; 83(2):e66-7. PubMed ID: 19135753
[TBL] [Abstract][Full Text] [Related]
13. Risperidone induced ventricular tachycardia.
Mazhar MN; Resch DS
Psychopharmacol Bull; 2010; 43(3):82-3. PubMed ID: 21150847
[TBL] [Abstract][Full Text] [Related]
14. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
[No Abstract] [Full Text] [Related]
15. Priapism resulting from sertralinerisperidone combination in a 30-year-old Nigerian man with schizophrenia.
Salawu FK; Mustapha H; Danburam A
Ann Afr Med; 2010; 9(3):195. PubMed ID: 20710115
[No Abstract] [Full Text] [Related]
16. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic prescribing and diabetes.
Agius M; Murphy CL; Win A; Zaman R
Psychiatr Danub; 2007 Jun; 19(1-2):89-90. PubMed ID: 17603422
[No Abstract] [Full Text] [Related]
18. Long-acting risperidone-induced periorbital edema.
Pelizza L
J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
[No Abstract] [Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. Rapid onset psychosis after reduction of the risperidone dose.
Molina JD; Solé S; Pablo Sd; López-Muñoz F; Santana G; Alamo C
Pharmacopsychiatry; 2008 Jul; 41(4):160-3. PubMed ID: 18651347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
